Clinical Trial Update: CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing lenalidomide plus dexamethasone versus dexamethasone alone in previously treated multiple myeloma has completed, with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Revlimid (lenalidomide)

Snippet

Sponsor: Celgene | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2010-03-03